Veran Medical Technologies Completes $30.6M VC Financing

Funding Rounds

▤ Summary

The company intends to use the funds for commercial expansion in the U.S. and entry into international markets.Led by CEO Jason Pesterfield, Veran develops image-guided endobronchial and percutaneous technology for diagnosis of lung cancer and therapy delivery.The company commercializes the SPiN Thoracic Navigation System, which includes a hybrid lung cancer diagnostic procedure called SPiNPerc.SPiNPerc combines two main platforms, navigational bronchoscopy and percutaneous navigation, to give physicians more tools in a single procedure to diagnose early stage lung cancer.The system and SPiNPerc are being used by cancer centers in the U.S. to enable physicians to navigate to suspicious nodules through either an endobronchial or percutaneous approach using a patient-specific airway map derived from a low dose CT scan.

$ Funding

$
Amount $25.0M Total raised
□
Date September 29, 2015 Announcement date
◎
Investors 3G Capital, Rex Health Ventures, Prolog Ventures, Advantage Capital Lead investors
▥
Company http://www.veranmedical.com Funded company

▥ Classifications

industries
HealthTech
applications
ERP & Process Management

◇ AskAI Classifications

Labels
Medical Software Healthcare Technology Diagnostic Software

▦ Linked Companies